chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This describes events regarding vaccine dose #2. First dose was not as bad although still had the soreness, mottled rash, lump, itchiness, and slight headache. Not nearly as bad as dose  #2.   Very sore injection site (not able to  sleep on side of injection). No treatment, still somewhat tender, not as bad.  Very large area of hot, red, circular mottled rash  - approximately 4-5 inches in size around injection site.  Site has decreased in size and area just looks like bruising now.  No treatment.  Still visible.  Very itchy. No treatment. Has mostly stopped itching.  Very large, hard lump underneath mottled area. No treatment. Has decreased in size, but still palpable.  Headache with dizziness. No treatment other than ibuprofen. Still have occasional headache.
Please note the dates of the vaccines above were as follows: #1 - 3/23/21 #2 - 4/14/21 #3 - 12/15/21  In January of 2023 we found a lump that was diagnosed in April 2021 as a recurrence of cervical cancer which has metastasized to stage IV. The original cervical cancer was stage I in 2015. A recurrence of stage I cervical cancer 7 years later is virtually unheard of. The only thing in my life that was different from the previous 7 years was getting vaccinated. I believe without a doubt that the vaccine caused my recurrence.
Information has been received from a RN concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approx 23Feb06, the pt developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Reviewed state immunization registry prior to client's appointment. Based on record, client due for 4th Dtap immunization. Client met age and interval for 4th dose. 4th Dtap given. While updating clients personal immunization card, noted 4 doses already documented. Upon further investigation, client had already received 4 Dtap immunizations, one historical dose had been missed and not been transcribed into state registry at a prior visit, thus inadvertently administering an extra Dtap.
Four days after receiving the flu vaccine (sept 19), I began to develop  Herpes like sores on my buttocks and perineum. These sores spread to my upper body, face, legs.  On September 25 the nerve damage was so bad I had urinary retention and had to be catheterized. CT scan and MRI were both negative. I am still dealing with the aftermath of this event. I am unable to work at this time as I cannot sit for hours like I did before Sept 15.  I am usually a very healthy person- exercise, eat right am of sound mind. This had truly affected my quality of life.
She received tdap and polio together in one shot. I noticed that her arm started to swell and become hot in the evening. She went to bed and when she woke up it was worse and as the day continued became worse. I took her to the doctor again and they said it was a localized swelling. I have pictures, it doesn't seem localized to me.
sick; got a reaction to it; Initial information was received on 13-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer.  This case involves patient (unknown demography) who was sick (illness) and got a reaction to it (vaccination complication), while the patient received INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient got sick (illness) and got a reaction to vaccine (vaccination complication) (unknown latency, non-serious events) following the administration of INFLUENZA VACCINE.  It was reported that the patient was so sick that couldn't even go to Thanksgiving dinner. So the patient will not pass this year.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the events.  There will be no information available on the lot number for this case.
angioedema - rash -syncope - dexamethasone 10mg I.M. -  start prednisone 40mg  Q.D. x 5 days (starting 8/10/21) - singular 10mg p.o. x 14 days -  - decreased edema and erythema of face post dexamethasone
Constant noticeable tinnitus. Started within 3 days after receiving the Janssen vaccine.
Fatigue setting in around 3 hours after vaccination, slept for an hour  Fever overnight (noticed at 3:00am), treated with 400mg ibuprofen  Mood pain in injection side, started around 4pm
Initial solicited pregnancy report received from a pharmacist on 05 February 2015. This is a retrospective pregnancy registry case for study.  A 30-year-old female subject had received an injection of Fluzone QIV intramuscularly (batch number: UI188AA, Expire date: 30 June 2015) dose, dose in series and site of administration was not reported on 03 February 2015. Subject had no illness at the time of vaccination. The subject's pre-existing physician diagnosed allergies, birth defects, medical conditions includes pregnancy. On 03 February 2015, two to three hours after vaccination subject had experienced jaw pain which has progressed to her gums, cheeks, and facial structures. The last menstrual period and estimated date of delivery was unknown. At the time of vaccination the subject was pregnant. Laboratory data and corrective treatment was not provided. At the time of this report the subject was not recovered from the events. Relationship to investigational product according to Company: associated. Relationship to investigational product according to Investigator: not reported Documents held by sender: none. Follow up information received on 30 December 2015: On 30 December 2015 at 10:30 am the reporter reported that she was unable to follow-up because they did not have the subject's pregnancy information or the information which was requested. It was additionally reported that the reporter did not have the subject's OB/Gyn or responsible physician's contact. However a follow up with the subject would be done. Sender's Comments: Follow-up information received on 14 January 2016: A 30-year-old female subject had received the study vaccine during her pregnancy on 03 February 2105. (information regarding LMP, date of conception, EDD or USG findings were unknown). She experienced non-serious adverse events of facial pain and gum pain on the same day of vaccination.
This spontaneous report as received from a registered nurse refers to a 13 month old patient (gender not reported). On 09-JUL-2014 the patient was vaccinated with M-M-R II (HSA) lot # H010134, 0.5 ml, subcutaneous that expired on 17-MAY-2014. No adverse effect was reported. Additional information has been requested.
This spontaneous report was received from a registered pharmacist refers to a 62 years old male patient who on 22-AUG-2012 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (lot number 0562AE, Exp. Date: 20-MAR-2013) that had been stored at room temperature since 17-JUL-2012. The pharmacist was not aware if the patient had experienced any adverse effects. Additional information has been requested.
Pt recv vax on 3/3/99; on same day pt exp swelling/ red/ itching at vax site, swollen face, periorbital edema
BECAME ILL AT 15:15 ON 3/16/2021. SYMPTOMS ARE SINUS CONGESTION, COUGH, FATIGUE, CHILLS, SWEATS, HEADACHE, BODY ACHES
Started having chest tightness and having a hard time catching my breath while talking or walking. Took 2 benadryl every 4 hours throughout the night. The next day I was still having a hard time breathing and called teledoc who prescribed some steroids as well as pepsid ac to get the reaction under control. Continued that for 7 days.
Patient with history of Urge incontinence, OSA, RLS, pseudogout, neuropathy, overactive bladder, arthritis, obesity, IBS, hypertension, hyperlipidemia, fibromyalgia, DM2, depression. Discharged from Medical Center after admission for fever and confusion thought to have enteritis presented to Hospital with Fever and confusion and found to be positive for COVID-19. .   Acute metabolic encephalopathy, resolved During her recent admission this was thought to be due to possible enteritis and had improved by discharge. Currently due to COVID-19. 1/22/2023 head CT with mild chronic ischemic changes and chronic sinusitis. B12, folate, ammonia, RPR, TSH, UA all unremarkable. Underwent lumbar puncture with negative PCR panel, aerobic culture no growth, protein 46, glucose 91, and white blood cell of 7. Prior UDS positive for barbiturate however she takes Fioricet at home. At baseline at discharge  this admission  Could consider neurocognitive evaluation outpatient to look for underlying dementia given her recurrent issues with confusion when she has infections.    Covid-19 Virus Infection Date of onset of symptoms: unclear  Symptoms present on admission: fever, confusion, cough  Date of covid positive test: 1/22/23 Vaccination status: vaccinated Imaging: CXR edema vs early pneumonia  Oxygen requirements on admission: room air  Current oxygen requirements: room air  Medical therapy: not a candidate given uncertain onset and on room air  Anticipated special isolation end date: 2/1/23   Fever Documented at 102.8 in the ED Chest x-ray with mild pulmonary vascular congestion. Abdominal CT with IV contrast with gallbladder largely distended but no visualized stones. 1/22/2023 blood culture no growth to date UA without signs of infection LFTs normal and no right upper quadrant tenderness Suspect this is due to COVID-19 and will monitor off antibiotics   History of enteritis Diagnosed during admission based on a CAT scan at that time with small intestinal air-fluid levels. Has completed antibiotics Hypertension, essential Continue home amlodipine and losartan   DM2 Holding home empagliflozin, liraglutide Continue home long-acting insulin 54 units each morning Take short acting insulin 18 units before dinner    OSA States she is not using CPAP currently
In August 2000, the patient developed shingles on his torso and down his leg. He was seen by his physician who initially diagnosed him with a rash and on a second visit, diagnosed his with shingles. The patient had severe pain which started 08/25/2000 and was treated with Tylenol with codeine and an unspecified cream. On 08/31/2000, a sample was sent for PCR analysis. Follow up information states the patient developed sever zoster with hundreds of vesicles, confluent in many areas, distributed on the right abdomen, back and upper thigh with an abrupt stop at midline. The patient was stated to have severe pain. It was reported that the patient has not had recent exposure to chickenpox or shingles. By 09/28/2000 the patient had completely recovered from the experience. The physician reported that some scarring was noted. No further information is expected.
SHINGLES VACCINE- REDNESS, SORENESS, AND ITCHING AT SITE OF INJECTION.
He tested positive for COVID-19 9/26/22. He had a fever, congestion, runny nose, and a cough. He is still having the symptoms at this time. They didn't recommend any medications for them. I have been giving him TYLENOL to keep the fever down.
Patient is a 80 y.o. male with past medical history significant for type 1 diabetes mellitus, with insulin pump, dumping syndrome, prior TIA, history of ampullary cancer, who presents to the emergency department today for evaluation of generalized weakness, multiple falls at home, and intractable nausea, vomiting.  He was recently admitted to the emergency department observation unit for similar symptoms, was found to have C difficile, and has since completed 10 days of oral vancomycin.   Since completing antibiotics, he reports significant improvement in diarrhea, but still having some. He reports dark brown bowel movements, denies tarry black stools or hematochezia.  He reports severe nausea and vomiting to the point of dry heaving.  Has not been able to eat any food over the past 24 hours secondary to this.  He does normally receive biweekly IV fluid infusions, but has required many increased infusions recently due to GI losses.   His nausea and vomiting is worse with palpation of the abdomen and with position changes. He is tender with palpation of his abdomen.  Denies fevers, chills.  He does report slight cough, but no significant dyspnea.  No chest pain. No urinary symptoms.    The patient arrived in the emergency department hemodynamically stable, afebrile and non-hypoxic on room air. CBC was unremarkable. CMP was remarkable for Na 133, glucose 119, alk phos 153. Mag and phos were normal. hstnt baseline 16, hstnt 2hr 15 (delta - 1).  The patient denies chest pain.  UA was unremarkable.  EKG was obtained and independently reviewed, with normal sinus rhythm, rate 83, QTC 415, no ischemic changes.  Chest x-ray was independently reviewed, with persistent right upper lobe opacity, similar apical scarring to past CXRs. CT head was independently reviewed, with mild intracranial volume loss and chronic small-vessel changes.  The patient was given 1 L normal saline, 4 mg IV Zofran.  The patient was admitted to the hospitalist service for further workup and management.
EPILEPSY, UNSPECIFIED 4/17/2023 CAD W ANGINA, W HX OF CABG
FEVER; FEELING VERY TIRED; This spontaneous report received from a patient via a company representative concerned a 21 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 15-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On NOV-2020, Laboratory data included: COVID-19 antibody test (NR: not provided) POSITIVE. On 16-JUL-2021, the subject experienced fever. On 16-JUL-2021, the subject experienced feeling very tired. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 16-JUL-2021, and had not recovered from feeling very tired. This report was non-serious.
Patient given COVID vaccine in 2/2021 now hospitalized with + Covid test 8/2021
At 1105, patient stood up and reported he "feels like I'm going to pass out" to RN. Patient advised to sit down. Patient reported history of panic attacks. Patient reported feeling "sweaty" and having "blurred vision". EMT sat down with patient. Patient closed eyes and started to slump in chair. EMT assisted patient to lay down on the floor. Patient opened eyes after approximately 5 seconds. Patient elevated legs on a chair. At 1111 RN assessed patient vital signs: blood pressure 118/76 mmHg and pulse 99 beats/minute. Patient reported no chronic conditions, no current medications, and no known allergies. At 1121, RN reassessed patient: blood pressure 122/78 mmHg, pulse 56 beats/minute, and SpO2 100%. At 1125, patient was able to stand up and sit in chair. Patient denied dizziness. Patient given water and gatorade. Patient able to drink water and gatorade. At 1131, RN reassessed patient vital signs: 130/100 mmHg, pulse 70 beats/minute and SpO2 100%. Patient denied dizziness and stated he was "feeling fine". RN educated patient on signs/symptoms of when to seek emergency care, to follow up with primary care provider, and to sign up on v-safe. At 1135, patient left facility with unlabored respirations and steady gait.
J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/21/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA R57.9 SHOCK, UNSPECIFIED 11/21/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/21/2021 PLEURAL EFFUSION R57.9 SHOCK, UNSPECIFIED 11/21/2021 PLEURAL EFFUSION J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/21/2021 UPPER BACK PAIN R57.9 SHOCK, UNSPECIFIED 11/21/2021 UPPER BACK PAIN
Patient reported dizziness  beginning about 12 hours after vaccination.   Patient hydrated at home and symptoms resolved after around 2 hours
After my second vaccine of moderna, my lymph nodes were enlarged.  Then 2 months later I got my period after being in menopause for over 5 years.  Since the vaccine I get my period every other month
inj site itchy, red, swollen about 5cm in diameter w/1-2 blisters since wk p/shot;29JUL98 redness & induration gone bad bruise about 2cm in diameter;
I had COVID-19 infection 2 times on 02/2022 and 07/2021. I was given prednisone before February for a cough I had. The adverse event happened on 05/2022. When I woke in the morning I had pain in every joints, and left hip except for my elbow. I called my doctor on 04/2022, and did a telehealth. She prescribed me LYRICA and tramadol. My doctor thought I have Acute Inflammatory Arthritis. She did few blood works and Pulmonary function test, CT-Scan which were all were normal. Late October and November I was having pain in my hip they diagnosed me as having Vascular Necrosis. I had a hip replacement done on November 17/2022. I had an MRI done for my hip because of the pain I was having on 10/2022.
Left sided weakness/facial droop, leg weakness and arm. Diagnosed with a stroke (CVA). The 60 day follow up states it was determined by a neurologist that the pt's symptoms were not related to the vaccine. Discharge Summary received on 8/27/2003 states encephalitis and mood disorder.
Muscle and joint pain on left arm that extended into shoulder and ribs. Swollen lymph nodes on left side of neck with pain.
38 year old received pediatric dose; Adult use of child product; This case was reported by a other health professional via call center representative and described the occurrence of underdose in a 38-year-old male patient who received HBV (Engerix B pediatric) (batch number 5295P, expiry date 27th December 2022) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 8th October 2021, the patient received Engerix B pediatric .5 ml and Engerix B Pre-Filled Syringe Device. On 8th October 2021, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The medical assistant reported that, an adult patient received a 0.5 ml pediatric dose of Engerix B, which led to underdose and adult use of a child product. No symptoms reported. The reporter consented to follow up. This case has been linked to US2021AMR216452, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR216452:same reporter
I gave Hepatitis A after a second check but did not chart it until after immunization was given. It expired 04/2022.
Approximately 3 days after receiving 2nd moderna vaccine, I woke-up with my eyes swollen then would not stop watering throughout the day, this turned into eczema on my eyes within days.  During the same time, blotchy rashes appeared all over my face, neck but a different hive-like pattern of rashes appeared on my chest and minimally on my thigh.  I also developed severe dermatitis on my fingers.  They swelled until they blistered and cracked.  The burning and itching was tremendous.  I had never experienced such fatigue either.  I had to wrap my fingers for weeks.  Throughout these symptoms, I went to Urgent Care and was placed on prednisone... it cleared up for about 3 days then returned full blast.  So then I went to dermatology who did an extended prednisone taper (& prescribed hydroxyzine).  Before that treatment course was even completed, symptoms were coming back so I saw a different doctor through my PCP office.  I was given an expensive steroid cream and a long-lasting steroid injection with benedryl.  Finally, the rashes across my face and chest were cleared up.  I was feeling like myself again having normal energy level, but that ended 3-4 days later.  I had a return visit to dermatology where a biopsy was completed (came back as an allergic reaction to either a medication or contact dermatitis).   A friend who's son battled severe eczema then had me try 2 creams for my hands which helped to heal the deep cracks and lose the callused skin; however, it's May 5, 2021 and my hands are flaring up (swollen to the point that 3 fingertips are turning maroon, starting to callus and I imagine will crack open within days again).  My energy levels are no where near my baseline.  I consume an awful lot of caffeine and sleep 10-12 hours a day/night in order to get through work and other tasks.  No one has been able to successfully treat me for 3 months now.    I will add that after my 1st vaccine on 1/7/21, a WEEK later, I had lip, tongue and throat swelling.  I took OTC allergy medicine around the clock for a week and symptoms subsided.  I reported this at the time of my 2nd injection and was told to proceed as it was "delayed" versus anaphylaxis.  I had no health issues prior.  My only known allergies/sensitivities over 38 years was penicillin (hives), cheap metals (rash) and cats... none of these have even came close for comparison of what I suspect the vaccine did to my immune system.  I work in a hospital and am very fearful I will have similar reactions to the flu vaccine now or worst, the COVID vaccine will be mandatory.
This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (warm), PAIN IN EXTREMITY (sore), INJECTION SITE PAIN (got real hard when needle went it, still tender when she rub at injection site) and INJECTION SITE RASH (red rash around injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Medical history not provided. The patient's past medical history included No adverse event (no medical records). Concomitant products included OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), LISINOPRIL and PRAVASTATIN for an unknown indication, INSULIN GLARGINE (LANTUS), DULAGLUTIDE (TRULICITY), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), FERROUS SULFATE, VITAMINS NOS (MULTIVITAMINS PLUS IRON) and PARACETAMOL (TYLENOL). On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE WARMTH (warm), PAIN IN EXTREMITY (sore), INJECTION SITE PAIN (got real hard when needle went it, still tender when she rub at injection site) and INJECTION SITE RASH (red rash around injection site). At the time of the report, INJECTION SITE WARMTH (warm), PAIN IN EXTREMITY (sore), INJECTION SITE PAIN (got real hard when needle went it, still tender when she rub at injection site) and INJECTION SITE RASH (red rash around injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Hives on left arm and neck. Diphenhydramine 25 mg once.
Received 2nd Covid Moderna injection 2-26-21, achy, weakness, lost consciousness 2-28-21 went to ER, low BP, and continued weakness, long QT interval, symptoms resolved in 2-3 weeks.
Really bad sore arm the night after the vaccine into the next day, headache, body aches, 100.00 fever, exhausted, leg pain in left leg
Around 6 hours after the shot, patient started feeling headaches. Later that evening came muscle pain, chills, high fever, nausea, vomiting, and migraines. The next day, most side effects went away except for the looming headache. Since the vaccine, patient has been experiencing episodes of dizziness and lightheadedness. There was an article that came out today as it relates to blood clots being a possible side effect of the vaccine and to report any feeling of headaches or possible symptoms that may be related to that.